The global landscape for medical technology, biotechnology and life sciences is on the cusp of seismic change.
A confluence of geopolitical tensions, economic uncertainty and evolving social values has created a complex web of challenges and opportunities for these sectors around the world.
The broad life sciences industry too is in the midst of significant transition. While the shadow of the pandemic recedes, its effects linger in the form of a market correction and an evolving healthcare landscape.
Check out the rest of the feature here
